Transcriptomics

Dataset Information

0

Effect of CD5-2 on endothelial cells with or without VE-cadherin expression


ABSTRACT: Purpose: The goals of this study are to confirm whether CD5-2 works through VE-cadherin Methods: mRNA profiles of HUVEC and VE-cadherin-/- EC treated with either control or CD5-2 were generated by deep sequencing using Illumina Hiseq4000 platform and 150 bp paired-end reads were generated. Reference genome and gene model annotation files were downloaded from genome website browser (NCBI/UCSC/Ensembl) directly. Indices of the reference genome were built using Bowtie (v2.2.3) and paired-end clean reads were aligned to the reference genome using TopHat (v2.0.12). Differentially expressed genes were then determined using DESeq R package (v1.12.0). The resulting P-values were adjusted using the Benjamini and Hochberg’s approach for controlling the False Discovery Rate (FDR). Genes with an adjusted P-value<0.05 and FDR<0.005 were assigned as differentially expressed. Results: 585 differentially expressed genes (DEGs) in CD5-2 treated ECs compared with control treated ECs (P < 0.05; false discovery rate [FDR] ≤ 0.005). In stark contrast to that seen in normal ECs, in VE-cadherin-/- ECs, no gene was significantly differently expressed between control and CD5-2 treated group when using the same cut-off criteria, Conclusions: Our study suggests VE-cadherin is essential for the CD5-2 mediated gene changes

ORGANISM(S): Mus musculus Homo sapiens

PROVIDER: GSE149948 | GEO | 2020/05/07

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-01-10 | GSE34948 | GEO
2021-11-30 | GSE189408 | GEO
2012-01-10 | E-GEOD-34948 | biostudies-arrayexpress
2012-09-01 | GSE37631 | GEO
2013-09-30 | GSE50437 | GEO
2021-09-09 | PXD018725 | Pride
2019-04-20 | GSE113403 | GEO
| PRJNA630680 | ENA
2021-01-25 | E-MTAB-10020 | biostudies-arrayexpress
2008-07-06 | GSE11674 | GEO